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Thymic B cells and central T cell
tolerance
Tomoyoshi Yamano, Madlen Steinert and Ludger Klein*
Institute for Immunology, Ludwig-Maximilians-University Munich, Munich, Germany
Central T cell tolerance is believed to be mainly induced by thymic dendritic cells and
medullary thymic epithelial cells. The thymus also harbors substantial numbers of B
cells. These may arise though intrathymic B lymphopoiesis or immigration from the
bloodstream. Importantly, and in contrast to resting “mainstream” B cells in the periphery,
thymic B cells display elevated levels of MHC class II and constitutively express CD80.
Arguably, their most unexpected feature is the expression of autoimmune regulator.
These unique features of thymic B cells result from a licensing process that involves
cross-talk with CD4 single-positive T cells and CD40 signaling. Together, these recent
findings suggest that B cells play a more prominent role as thymic APCs than previously
appreciated.
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Introduction
B cells represent approximately 0.3% of the thymic cellularity. Although their absolute number may,
in fact, exceed that of thymic dendritic cells, their role a APCs for central tolerance induction is not
well understood, and thymic B cells have often been regarded as “innocent bystanders.” Recent data
suggest that this viewmay need to be revised. Here, wewill provide a short overview of novel insights
into distinct features of thymic B cells and how these may predispose thymic B cells to support T cell
tolerance.
The Origin of Thymic B Cells
Intrathymic B Cell Development
The early thymic progenitor (ETP), i.e., the cell type that gives rise to the T cell lineage, retains some
B cell potential (1). Notch signaling is essential for T lineage specification in ETPs, so that precursors
lacking Notch-1 fail to generate T lineage cells in the thymus. There are increased numbers of B cells
in the thymus of conditional Notch-1 knockout mice (2), and this was interpreted to indicate that
in the absence of Notch signaling, ETPs undergo B cell differentiation as a “default cell fate” (3, 4).
However, subsequent experiments argued that most of the accumulation of thymic B cells under
these conditions is not a cell intrinsic effect of Notch-deficiency, but may stem from immigration
of peripheral B cells as a result of excessive niche availability (5). This notion is supported by the
observation that perturbations in T cell differentiation downstream of the loss of B lineage potential
result in effects on thymic B cell numbers that are reciprocal to their effects on T cell numbers.
Specifically, TCRβ /  mice, in which T cell development is blocked prior to pre-TCR expression,
harbor a drastically diminished overall T cell compartment (arrested at the DN3 stage), yet have a
10-fold increase in thymic B cell numbers, whereas TCRα /  mice, in which T cell differentiation
is arrested at the DP stage, display slightly decreased numbers of B cells in the thymus (6, 7).
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Does intrathymic B cell differentiation occur under non-
perturbed steady state conditions? There were early reports on the
existence of cells within the thymus whose phenotype – surface
(s)IgM B220+CD43+ – resembled that of B cell progenitors
in the bone marrow (BM). When these cells were purified and
injected intrathymically (i.t.), they gave rise to mature B cells
within the thymus (8). Akashi et al. estimated that concomitant to
the release of about 1 106 T cells, the thymus also exports around
3 104 B cells each day (6). In sum, there is good evidence that
part of the thymic B cell population arises through differentiation
within the thymus.
Immigration of Peripheral B Cells
Using more conclusive surface marker combinations, we recently
revisited the issue whether the thymus harbors significant
numbers of B cell precursors (9). Among CD19+IgM IgD 
BM cells, pre- and pro-B cells are commonly identified as
CD2+c-Kit  and CD2 c-Kit+ cells, respectively. We found
that around one-third of thymic CD19+ cells were surface
IgM IgD , and thereby resembled B cell precursors in the
BM.However, pro-B cells (CD19+IgM IgD CD2 c-Kit+) were
essentially undetectable in the thymus. Moreover, most thymic
CD19+IgM IgD CD2+c-Kit  cells expressed surface sIgG.
Thus, the majority of CD19+IgM IgD  cells in the thymus
(unlike their phenotypic counterparts in the BM) are class-
switched mature B cells and not B cell precursors. Based upon
the paucity of B cell precursors in the thymus, we wondered
whether peripheral B cells enter the thymus in the steady state.
In order to address this, we intravenously injected bulk splenic
B cells into syngeneic hosts. Seven days later, donor B cells were
detectable in both spleen and thymus, whereby the relative abun-
dance among host B cells in the thymus was about 5- to 10-
fold lower as compared to the spleen. Although at first glance,
this suggests that thymic immigration is a fairly efficient pro-
cess, any comparison of its efficacy in relation to homing to the
spleen is blurred by the fact that upon entering the thymus, B
cells undergo several cell divisions. The capacity to enter the
thymus does not seem to be restricted to any particular activa-
tion state, since purified naïve B cells (IgM+IgD+) also entered
the thymus.
Taken together, it is reasonable to assume that both
intrathymic B lymphopoesis and immigration of BM-derived
B cells contribute to the thymic B cell pool. However, we
lack a precise understanding of the relative contribution
of either pathway. On the one hand, the virtual absence of
pro- and pre-B cells may render intrathymic differentiation
an unlikely source of the majority of thymic B cells. On
the other hand, thymic B cells in parabiosed mice do not
equilibrate to the same extent as is observed for splenic B cells,
insinuating a substantial contribution of intrathymic B cell
differentiation (10). Unraveling the lineage relation between
peripheral “mainstream” B cells and thymic B cells remains
experimentally challenging. Ultimately, this issue is linked to
the questions whether thymic B cells display distinct features,
and whether these features are manifestations of a hard-wired
“thymic B lineage differentiation program” or result from
extrinsic cues.
Intrathymic B Cell Licensing
The Unusual Phenotype of Thymic B Cells
Some phenotypic features (e.g., CD5 expression) had suggested
that thymic B cells may be related to the fetal liver-derived B1
lineage (8). However, whereas bona fide B1 cells in the peritoneal
cavity are restored only by reconstitution with fetal liver cells,
but not BM cells, the thymic B cell pool is efficiently gener-
ated from both precursors (10). Thus, thymic B cells clearly are
genealogically related to the B2 “mainstream” B cell lineage.
Unlike resting B cells in spleen and lymph node, thymic B
cells express high levels of MHC class II and the co-stimulatory
molecules CD80 and CD86 (9–11). Moreover, a substantial frac-
tion of thymic B cells have class-switched, whereby the distri-
bution of isotype classes is remarkably stereotypic from mouse
to mouse. Perhaps the most unusual feature of thymic B cells is
their expression of the autoimmune regulator (Aire) gene. Aire
is known to be crucial for “promiscuous gene expression” (pGE)
of peripheral self-antigens in medullary thymic epithelial cells
(mTECs) (12). The only cell-type other than mTECs that had
so far been reported to express Aire is rare cells in the lymph
node which have been termed as extrathymic Aire expressing
cells (eTACs) (13). eTACs are of hematopoietic origin, yet their
exact lineage identity remains elusive (14). Using Aire-reporter
mice, we noted a reporter-positive population of non-mTEC
cells in the thymus and subsequently identified these cells as
thymic B cells (9). Faithful expression of the Aire-reporter was
confirmed by RT-PCR and intracellular protein staining. Aire
protein was detectable in nuclear dots in around 2–3% of thymic
B cells, whereby protein levels were substantially lower than in
mTECs. A comparison of gene expression profiles in WT versus
Aire /  thymic B cells revealed that several hundred genes are
differentially expressed. Very few of these had previously been
reported to be Aire dependent in mTECs or eTACs, indicating
that Aire’s function as a transcriptional regulator is cell context
dependent. Of note, whereas in mTECs the expression of several
thousand genes is modulated by Aire, only a few hundred genes
are controlled by Aire in thymic B cells or eTACs. Furthermore, it
remains to be established whether Aire-dependent expression of
any tissue-restricted antigen in thymic B cells is essential for T cell
tolerance.
Are these distinctive features of thymic B cells an inherent
feature of B cells that arise through intrathymic B lympopoiesis?
To address this question, we followed the fate of i.v. injected
IgM+IgD+ B cells, which are MHCIIintermediate, CD80  and
Aire . Seven days after injection, donor cells in the spleen had
retained their initial phenotype. In contrast, cells that had immi-
grated into the thymus recapitulated all features of steady state
thymic B cells, indicating that the unique phenotype of thymic B
cells is imprinted by extrinsic cues in the thymic microenviron-
ment, and we referred to this microenvironmental programing as
“thymic B cell licensing” (9).
Thymic B Cell Licensing Requires CD40
The transition from a MHCIIintCD80 Aire  stage to a
MHCIIhiCD80+Aire+ phenotype during thymic B cell licensing
is strikingly reminiscent of mTEC “maturation.” However,
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whereas mTEC maturation is orchestrated by RANK signals
(15–17), thymic B cell licensing crucially requires another
TNF family member, CD40. Treatment of splenic B cells
with agonist anti-CD40 antibody emulated B cell licensing,
including induction of Aire (9). Thymic B cells in Cd40 / 
and Cd40lg /  mice are substantially diminished, consistent
with a role of CD40 signals in thymic B cell homeostasis (7).
Strikingly, the phenotype of thymic B cells in the absence
of CD40 signaling is that of resting peripheral B cells. Thus,
distinct signaling axes control the expression of Aire and the
acquisition of a MHCIIhighCD80+ phenotype in mTECs or
thymic B cells.
Cross-Talk with Autoreactive CD4 T Cells
Regulates Thymic B Cell Numbers and Licensing
Fujihara et al. showed that thymic B cell numbers are regu-
lated by CD4 single-positive (SP) thymocytes (7). Similarly, we
found that thymic B cells from TCRα /  mice, which lack SP
thymocytes, express low levels of MHCII, are negative for co-
stimulatory molecules, do not undergo class-switching and fail
to up-regulate Aire (9). Strikingly, although CD4 SP thymocytes
in “monoclonal” OT2 TCR transgenic mice on TCRα /  back-
ground express normal levels of CD40L, B cells in these mice
are not licensed, indicating that a polyclonal repertoire of CD4
SP cells is necessary. The requirement for diverse TCRs seems to
reflect a critical role of autoreactivity within the nascent CD4 SP
compartment. Along these lines, B cell licensing can be mimicked
in vitro when splenic B cells are pulsed with cognate antigen
and co-cultured with specific CD4 SP cells. Moreover, MHCII-
deficient B cells do not undergo licensing upon immigration into
the thymus. Together, these observations suggest that cognate
interactions through direct antigen presentation by B cells pro-
vide a platform for CD40 signaling and thereby initiate licensing
(Figure 1). This tolerogenic feed-forward loop represents a strik-
ing parallel to the very similar cross-talk between mTECs and
CD4 SP cells that is thought to bolster the tolerogenic features of
mTECs (18).
Thymic B Cells and Central T Cell
Tolerance
Evidence for a Non-Redundant Contribution of
Thymic B Cells to Central Tolerance
Several studies have shown that thymic B cells can contribute
to negative selection under particular experimental conditions.
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FIGURE 1 | Sequential phases of thymic B cell licensing. (1)
Recirculating peripheral B cells can enter the thymus. Their peptide
(p)MHCII ligandome is expected to mostly contain endogenously expressed
“resting B cell autoantigens.” Whereas the peripheral T cell repertoire is
likely to be robustly tolerant toward these self-antigens, the nascent CD4
SP compartment is not (yet) fully purged of the respective specificities. (2)
An unknown fraction of “B cell-reactive” CD4 SP cells within the diverse
CD4 SP repertoire recognize “resting B cell autoantigens” and provide
CD40 signals. CD40L is constitutively expressed by CD4 SP cells
regardless of autoreactivity, presumably as a consequence of preceeding
positively selecting interactions with cTECs. (3) Cross-talk with CD4
single-positive thymocytes induces proliferation, up-regulation of MHC
class II, induction of CD80, induction of Aire, and Ig class-switching. (4)
Licensed B cells delete autoreactive CD4 T cells, including TCR specificities
that recognize “licensing-dependent” self-antigens; these are expected to
include, but are not restricted to, self-antigens that are also up-regulated in
activated B cells in the periphery (Type A) and Aire-dependent self-antigens
(TRAs) (Type B).
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cells led to deletion of superantigen reactive T cells (19). Myelin
oligodendrocyte glycoprotein (MOG)-specific CD4+ thymocytes
were negatively selected when an epitope of MOGwas exclusively
presented by B cells (20). Perera et al. used autoreactive B cell
receptor (BCR) transgenic mice to show that cognate T cells of
the “same specificity” were negatively selected in the thymus (10).
We showed that a “licensing-dependent” neo-antigen selectively
up-regulated in immigrating B cells mediated negative selection
through direct presentation (9).
What is known about the overall contribution of thymic B cells
to central T cell tolerance? In mice lacking B cells, the size of the
CD4SP cell compartment is significantly increased (9, 21). This
resembles previous observations in mice that either lacked DCs
or had a diminution of MHCII on mTECs, suggesting a non-
redundant contribution of thymic B cells to negative selection of
CD4 T cells (22, 23). Other recent reports showed that thymic
Treg cells are decreased in B cell-deficient mice, and increased
Treg numbers were observed in the thymus of Baff-transgenic
mice harboring elevated B cell numbers (21, 24). Although these
findings support a role of thymic B cell for central tolerance
induction under physiological conditions, the exact spectrum of
self-antigens that may require such a contribution remains to be
characterized.
Do Thymic B Cells Pre-Empt the Self-Antigen
Signature of Germinal Center B Cells?
The role of CD40 and the cognate interactions between B cells
and CD4 T cells during thymic B cell licensing are reminiscent
of the germinal center (GC) reaction (25). Indeed, a substan-
tial fraction of thymic B cells display a Fas+GL7+ phenotype
that is otherwise characteristic for GC B cells (9). It is therefore
tempting to speculate that the tolerogenic potential of licensed
thymic B cells might in particular comprise “activated-B-cell”
autoantigens. Consistent with that idea, CD4 SP thymoctes from
B cell-deficient mice are hyper-responsive to CD40-activated B
cells (9). A central assumption of the GC paradigm is that CD4
T cell help needs to be tightly focused on epitopes of the for-
eign antigen that has been internalized via the BCR (26). In
order to control BCR–hypermutation-related neo-autoreactivity
among GC B cells, self-reactive B cells need to be deprived
from cognate help. This not only requires robust CD4 T cell
tolerance toward exogenously derived self-determinants that have
been captured via the hypermutated BCR but also that the CD4
T cell repertoire is efficiently purged of reactivity toward any
endogenously derived B cell autoantigen that is concurrently pre-
sented. Because thymic B cells may emulate the peptide/MHC
composition of GC B cells in a tolerogenic setting, thymic B cell
licensing may pre-empt T cell recognition of “activated B cell
autoantigens” in an inflammatory context in secondary lymphoid
tissues.
A Role for the BCR?
B cells efficiently present antigens that have been captured via
the BCR (27). So, do BCR-specificity and/or -autoreactivity play
a role in thymic B cell licensing and B cell-mediated central
tolerance? Using BCR knock-in and T cell receptor transgenic
mice specific for the same antigen, Perera et al. elegantly demon-
strated that autoreactive B cells are particularly efficient APCs
to induce negative selection of T cells with identical specificity
(10). However, we found no evidence that BCR autoreactivity
may favor B cell entry into the thymus or is a prerequisite to
subsequently undergo licensing (9). Specifically, we employed
SWHEL mice to address these issues. In these mice, around two-
thirds of peripheral B cells express a transgenic “anti-foreign BCR”
specific for hen egg lysozyme (HEL), whereas the remainder of B
cells carry endogenously rearranged BCRs, some of which may
harbor autoreactivity. The relative abundance of HEL+ B cells
in the thymus exactly reflected their peripheral frequency, and
both HEL+ and HEL  B cells underwent intrathymic licensing.
Future work is needed to more conclusively address the compo-
sition of the thymic B cell repertoire, for instance, through BCR
sequencing.
Open Questions
Is BCR Class-Switching in the Thymus
Physiologically Relevant?
As a consequence of licensing, thymic B cells class-switch to IgG
or IgA. It is therefore conceivable that thymic B cells present B
lineage-specific “neo-epitopes” generated through isotype-class-
switching or possibly also somatic hypermutation. In all likeli-
hood, and in distinction from the GC reaction, class-switching
in the thymus may occur “spontaneously,” i.e., independent of
cognate help downstream of BCR-mediated antigen capture.
This has obvious implications for the emergence of “natural”
Igs. Some thymic B cells display a memory B cell pheno-
type (CD38+Faslo), and it is possible that IgG- or IgA-positive
thymic B cells re-enter the blood stream. In fact, we observed
a minute population of class-switched donor cell in the periph-
ery after intrathymic injection of naive B cells (Tomoyoshi
Yamano and Ludger Klein unpublished). More work is needed
to clarify the role of the thymus as a potential source of natu-
ral Igs.
Do Thymic B Cells Shape the Thymic
Microenvironment?
It was shown that thymic B cells express Ltα and Ltβ, and
thereby regulatemTEC cellularity (28). Thymic B cells also express
a variety of cytokines and chemokines, e.g., IL-10, IL-12, IL-
16, and CCL22 (Tomoyoshi Yamano and Ludger Klein unpub-
lished). These data suggest additional layers of cross-talk in
the thymus. However, more work is needed to better under-
stand whether and how thymic B cells may organize the thymic
microenvironment.
Do Thymic B Cells Play a Role in Human Disease?
The presence of B cells with an “activated” phenotype in the
healthy human thymus has long been recognized (29), but their
origin and specificity has remained elusive. Ectopic GC-like
structures are present in thymi of early-onset myasthenia gravis
(MG) patients, and it was hypothesized that they are the site of
auto-sensitization against the acetylcholine receptor (AChR) (30).
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However, a recent characterization of antibody repertoires in MG
thymi revealed expansion of a polyclonal repertoire unrelated to
AChR specificities (31). Thus, it remains to be shown whether the
accumulation of B cells in MG thymi is a cause or a consequence
of disease.
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